| Literature DB >> 34976497 |
Saqib Kamran Bakhshi1, Anum Sadruddin Pidani2, Mujtaba Khalil3, Muhammad Shahzad Shamim1.
Abstract
Introduction Brain tumor resection under awake settings may cause significant psychological stress, which may lead to perioperative anxiety and depression. We conducted a prospective study to compare postoperative depression in patients undergoing awake craniotomy (AC) for tumor resection and compare it with patients undergoing tumor resection under general anesthesia (GA). Methods We conducted a prospective study at a tertiary care hospital. Non-probability consecutive sampling was performed, and patients with a preoperative diagnosis of depression or with any other medical comorbidities that could precipitate depression were excluded. Two separate questionnaires, the Patient Health Questionnaire-9 (PHQ-9) Scale and the Karnofsky Performance Score (KPS), were used to screen depression and assess functional status, respectively. Results Ninety-six patients met the inclusion criteria and were included in the study. Out of these, 37 (38.1%) had undergone awake craniotomy and 59 (60.8%) had undergone conventional craniotomy (CC) (under general anesthesia) for brain tumor resection. To standardize our method, we ensured that the demographic variables, including mean age, gender, educational status, marital status, and socioeconomic conditions, were comparable between both groups. Postoperative functional status fared better in patients who underwent awake craniotomy (p = 0.03). The total number of patients suffering from postoperative clinical depression, according to the PHQ-9 Scale, was 41 (42.7%), of which 12 (12.5%) were in the awake craniotomy group and 29 (30.2%) were in the conventional craniotomy group. The median PHQ-9 Scale score in the awake craniotomy group was 6 (range: 3-10), which was less than the median score in the conventional craniotomy group, which was 9 (range: 4-12). This difference, however, was not statistically significant (p = 0.06). Conclusion Resection of brain tumors under awake conditions is not likely associated with any additional incidence of postoperative depression when compared with resection of tumors under general anesthesia.Entities:
Keywords: awake craniotomy; brain tumor; depression; fear; psychological stress
Year: 2021 PMID: 34976497 PMCID: PMC8712220 DOI: 10.7759/cureus.19877
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Comparison of basic demographics between the two groups
SES: socioeconomic status
| Parameters | Awake craniotomy ( N = 37) | Conventional craniotomy ( N = 59) | P-value |
| Age (years) | Mean: 41.56 ± 12.28 | Mean: 43.72 ± 11.71 | 0.39 |
| Gender | |||
| Male | 21 (56.76%) | 42 (71.19%) | 0.18 |
| Female | 16 (43.24%) | 17 (28.81%) | |
| Educational status | |||
| Class 1–9 | 6 (16.22%) | 13 (22.03%) | 0.81 |
| Matriculation | 6 (16.22%) | 13 (22.03%) | |
| Intermediate | 7 (18.92%) | 7 (11.86%) | |
| Bachelor’s degree | 12 (32.43%) | 18 (30.51%) | |
| Master’s/doctorate degree | 6 (16.22%) | 8 (13.56%) | |
| Marital status | |||
| Married | 33 (89.19 %) | 4 (10.81%) | 1.00 |
| Single/divorced/widowed | 53 (89.83%) | 6 (10.17%) | |
| Children under 18 years | |||
| Yes | 23 (62.16%) | 31 (52.54%) | 0.70 |
| No | 9 (24.62%) | 17 (28.81%) | |
| Current employment status | |||
| Able to work | 17 (45.95%) | 28 (47.46%) | 0.26 |
| Unable to work | 5 (13.51%) | 15 (25.42%) | |
| Others (retired/student/housewife) | 15 (40.54%) | 16 (27.12%) | |
| Caregiver at home | |||
| Spouse | 23 (62.16%) | 46 (77.97%) | 0.10 |
| Parents | 3 (8.11%) | 6 (10.17%) | |
| Others (kids/neighbor/sibling/self) | 11 (29.73%) | 7 (11.86%) | |
| Head of the family | |||
| Yes | 16 (43.24%) | 33 (55.93%) | 0.29 |
| No | 21 (56.76%) | 26 (44.07%) | |
| SES | |||
| Low SES | 2 (5.41%) | 11 (18.64%) | 0.07 |
| Middle SES | 30 (81.08%) | 36 (61.02%) | |
| High SES | 5 (13.51%) | 12 (20.34%) | |
| Treatment cost management | |||
| Self-support | 21 (56.76%) | 31 (52.54%) | 0.19 |
| Family/relative support | 7 (18.92%) | 7 (11.86%) | |
| Welfare from treating hospital | 5 (13.51%) | 18 (30.51%) | |
| Support from community | 4 (10.81%) | 3 (5.08%) | |
| Health insurance | |||
| Yes | 6 (16.22%) | 7 (11.86%) | 0.55 |
| No | 31 (83.78%) | 52 (88.14%) | |
Comparison of clinical variables between the two groups
| Parameters | Awake craniotomy ( N = 37) | Conventional craniotomy ( N = 59) | P-value |
| Currently smoking | |||
| Yes | 4 (10.81%) | 9 (15.25%) | 0.76 |
| No | 33 (89.19%) | 50 (84.75%) | |
| History of psychological distress prior to diagnosis of brain tumor | |||
| Yes | 1 (2.70%) | 4 (6.78%) | 0.29 |
| No | 36 (97.30%) | 55 (93.22%) | |
| Karnofsky Performance Score (functional status) | |||
| KPS score > 70 | 31 (83.78%) | 37 (62.71%) | 0.03 |
| KPS score ≤ 70 | 6 (16.22%) | 22 (37.29%) | |
| Treatment stage at the time of interview | |||
| Only surgical procedures done | 3 (8.11%) | 13 (22.03%) | 0.01 |
| Referred to oncology after surgery | 5 (13.51%) | 13 (22.03%) | |
| Oncology treatment started/continued | 16 (43.24%) | 9 (15.25%) | |
| Treatment completed/follow-ups | 13 (35.14%) | 24 (40.68%) | |
| Current use of steroids | |||
| Yes | 4 (10.81%) | 15 (25.42%) | 0.11 |
| No | 33 (89.19%) | 44 (74.58%) | |
| Current use of antiepileptic drugs | |||
| Yes | 17 (45.95%) | 31 (52.54%) | 0.67 |
| No | 20 (54.05%) | 28 (47.46%) | |
| Tumor type | |||
| Low grade (grade I and II) | 8 (21.62%) | 25 (42.37%) | 0.04 |
| High grade (grade III and IV) | 29 (78.38%) | 34 (57.63%) | |
| Hemispheric lateralization | |||
| Left | 27 (72.79%) | 32 (54.24%) | 0.10 |
| Right | 9 (24.32%) | 26 (44.07%) | |
| Not specified | 1 (2.70%) | 1 (1.69%) | |
| Tumor grade | |||
| Grade I | 5 (13.51%) | 7 (11.86%) | 0.59 |
| Grade II | 9 (24.32%) | 20 (33.90%) | |
| Grade III | 13 (35.14%) | 17 (28.81%) | |
| Grade IV | 8 (21.62%) | 8 (13.56%) | |
| Not specified | 2 (5.41%) | 7 (11.86%) | |
| Cognitive impairment | |||
| Yes | 2 (5.41%) | 6 (10.17%) | 0.48 |
| No | 35 (94.59%) | 53 (89.83%) | |
| Tumor recurrence | |||
| Yes | 7 (18.92%) | 12 (20.34%) | 1.00 |
| No | 30 (81.08%) | 47 (79.66%) | |
| Duration since diagnosis (in months) | Median: 7 (2–15) | Median: 6 (1–17) | 0.52 |
| Patient Health Questionnaire-9 (PHQ-9) Scale scores | 6.72 ± 5.17 (median: 6 (3–10)) | 8.86 ± 8.86 (median: 9 (4–12)) | 0.06 |